Senseonics brings one-year Eversense 365 CGM to Beta Bionics iLet platform
Senseonics and Beta Bionics plan to integrate Eversense 365 with iLet, pairing one-year implantable CGM with automated insulin delivery.
Senseonics and Beta Bionics plan to integrate Eversense 365 with iLet, pairing one-year implantable CGM with automated insulin delivery.
Beta Bionics wins FDA clearance for Mint, targets a Q1 2027 launch and prices a $150 million offering to support commercialization.